Name | Relationship | Address | Signature | Signature date | CIK |
---|---|---|---|---|---|
Deschatelets Pascal | Chief Scientific Officer | C/O APELLIS PHARMACEUTICALS, INC., 100 FIFTH AVENUE, 3RD FLOOR, WALTHAM | /s/ David Watson, attorney-in-fact for Pascal Deschatelets | 2025-06-11 | 0001657720 |
Id | Content |
---|---|
F1 | This represents stock option award granted on June 9, 2025, which will vest over a two-year period. Specifically, 50% of the options will vest on each of the one-year and two-year anniversaries of the grant date, contingent upon continued service. |